Waters Comprehensive Income 2010-2024 | WAT
Waters comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Waters comprehensive income for the quarter ending September 30, 2024 was $-0.132B, a 9.58% decline year-over-year.
- Waters comprehensive income for 2023 was $-0.134B, a 5.26% decline from 2022.
- Waters comprehensive income for 2022 was $-0.142B, a 26.56% increase from 2021.
- Waters comprehensive income for 2021 was $-0.112B, a 5.15% decline from 2020.
| Waters Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-134 |
| 2022 | $-142 |
| 2021 | $-112 |
| 2020 | $-118 |
| 2019 | $-119 |
| 2018 | $-118 |
| 2017 | $-110 |
| 2016 | $-216 |
| 2015 | $-147 |
| 2014 | $-79 |
| 2013 | $6 |
| 2012 | $-26 |
| 2011 | $-36 |
| 2010 | $-12 |
| 2009 | $16 |
| Waters Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-132 |
| 2024-06-30 | $-148 |
| 2024-03-31 | $-142 |
| 2023-12-31 | $-134 |
| 2023-09-30 | $-146 |
| 2023-06-30 | $-129 |
| 2023-03-31 | $-133 |
| 2022-12-31 | $-142 |
| 2022-09-30 | $-164 |
| 2022-06-30 | $-141 |
| 2022-03-31 | $-118 |
| 2021-12-31 | $-112 |
| 2021-09-30 | $-116 |
| 2021-06-30 | $-111 |
| 2021-03-31 | $-111 |
| 2020-12-31 | $-118 |
| 2020-09-30 | $-127 |
| 2020-06-30 | $-127 |
| 2020-03-31 | $-138 |
| 2019-12-31 | $-119 |
| 2019-09-30 | $-120 |
| 2019-06-30 | $-115 |
| 2019-03-31 | $-109 |
| 2018-12-31 | $-118 |
| 2018-09-30 | $-126 |
| 2018-06-30 | $-133 |
| 2018-03-31 | $-89 |
| 2017-12-31 | $-110 |
| 2017-09-30 | $-120 |
| 2017-06-30 | $-148 |
| 2017-03-31 | $-187 |
| 2016-12-31 | $-216 |
| 2016-09-30 | $-155 |
| 2016-06-30 | $-157 |
| 2016-03-31 | $-128 |
| 2015-12-31 | $-147 |
| 2015-09-30 | $-127 |
| 2015-06-30 | $-118 |
| 2015-03-31 | $-138 |
| 2014-12-31 | $-79 |
| 2014-09-30 | $-10 |
| 2014-06-30 | $39 |
| 2014-03-31 | $32 |
| 2013-12-31 | $6 |
| 2013-09-30 | $-25 |
| 2013-06-30 | $-54 |
| 2013-03-31 | $-55 |
| 2012-12-31 | $-26 |
| 2012-09-30 | $-29 |
| 2012-06-30 | $-54 |
| 2012-03-31 | $-23 |
| 2011-12-31 | $-36 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $32 |
| 2011-03-31 | $22 |
| 2010-12-31 | $-12 |
| 2010-09-30 | $4 |
| 2010-06-30 | $-36 |
| 2010-03-31 | $-8 |
| 2009-12-31 | $16 |
| 2009-09-30 | $19 |
| 2009-06-30 | $9 |
| 2009-03-31 | $-21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.880B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.408B | 24.08 |
| Intuitive Surgical (ISRG) | United States | $196.120B | 102.54 |
| Alcon (ALC) | Switzerland | $42.207B | 28.24 |
| Edwards Lifesciences (EW) | United States | $41.510B | 26.36 |
| IQVIA Holdings (IQV) | United States | $35.864B | 19.76 |
| IDEXX Laboratories (IDXX) | United States | $34.273B | 40.36 |
| DexCom (DXCM) | United States | $29.084B | 43.80 |
| STERIS (STE) | Ireland | $21.298B | 24.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.458B | 0.00 |
| Hologic (HOLX) | United States | $18.284B | 19.29 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.898B | 13.24 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.562B | 29.28 |
| Penumbra (PEN) | United States | $9.230B | 90.41 |
| Masimo (MASI) | United States | $9.055B | 43.81 |
| Teleflex (TFX) | United States | $8.854B | 14.12 |
| Glaukos (GKOS) | United States | $7.765B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.929B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| Veracyte (VCYT) | United States | $3.018B | 90.56 |
| Inari Medical (NARI) | United States | $2.913B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.807B | 16.21 |
| TransMedics (TMDX) | United States | $2.663B | 84.40 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 18.44 |
| Elekta AB (EKTAY) | Sweden | $2.125B | 17.31 |
| Tandem Diabetes Care (TNDM) | United States | $2.019B | 0.00 |
| RxSight (RXST) | United States | $1.816B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.775B | 9.27 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Artivion (AORT) | United States | $1.175B | 77.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.992B | 0.00 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.828B | 14.08 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.714B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.548B | 12.91 |
| SiBone (SIBN) | United States | $0.515B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 32.40 |
| Tactile Systems Technology (TCMD) | United States | $0.383B | 20.70 |
| CVRx (CVRX) | United States | $0.358B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.315B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| NeuroPace (NPCE) | United States | $0.269B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.150B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.67 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |